Synthesis and spectroscopic characterization of double chained and sulfurated

derivatives of L-ascorbic acid by Tanini, Damiano et al.
DOI: http://dx.doi.org/10.3998/ark.5550190.p009.781 Page 407 
©
ARKAT USA, Inc 
 
The Free Internet Journal 
for Organic Chemistry 
Paper 
Archive for 
Organic Chemistry 
 Arkivoc 2017, part ii, 407-420 
 
Synthesis and spectroscopic characterization of double chained and sulfurated 
derivatives of L-ascorbic acid 
 
Damiano Tanini, Marianna Gori, Francesco Bicocchi, Moira Ambrosi, Pierandrea Lo Nostro,  
and Antonella Capperucci* 
 
Dipartimento di Chimica ”Ugo Schiff”, Università di Firenze, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, 
Italy 
E-mail: antonella.capperucci@unifi.it  
 
Dedicated to Prof. Jacek Młochowski on the occasion of his 80
th
 anniversary 
Received   07-04-2016  Accepted 09-23-2016  Published on line 12-04-2016 
 
Abstract 
Lipophilic saturated and unsaturated L-ascorbyl 5,6-O-diesters from fatty acids are prepared and fully 
characterized through NMR and MS spectra. Derivatives with different sulfurated moieties are obtained as 
well through thio-Michael addition of thiols on ascorbyl acrylates. The new amphiphilic structures exhibit very 
high antioxidant activity using the DPPH assay. 
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Introduction 
 
Antioxidants are widely used in different fields, for example the food, cosmetic and pharmaceutical industries. 
Our interest in the chemistry of sulfurated and selenated compounds led us to develop an access to organo-
chalcogen derivatives, such as selenides, diselenides and heterocyclic compounds,
1-6
 which evidenced 
interesting antioxidant activity. The chemistry of organosulfur, and more recently of organoselenium 
compounds has in fact experienced a strong development.
7,8
 Such derivatives are used as reagents in organic 
synthesis and, due to their interest from the biological point of view, in the preparation of molecules with 
biological activity. Recently we were involved in the study of modifications of natural products, with the aim to 
introduce on the same molecular skeleton sulfurated or selelenated moieties, which could possess a 
synergistic effect together with the natural core. We found a convenient method for the synthesis of 
selenium-derivatives of resveratrol as antioxidants and free radical scavengers.
9 
These structures evidenced 
antioxidant activity with Trolox-like capacity. 
In this context considerable interest has also been devoted to the study of liposoluble ester derivatives of  
L-ascorbic acid (L-ASC), which is a well known, potent and versatile antioxidant. Their physico-chemical 
properties have been extensively investigated
10-17 
in particular their phase behavior in the solid state and in 
aqueous dispersions. The amphiphilic derivatives of ascorbic acid fully retain the antioxidant power of the 
parent molecule, and produce nanostructured self-assembled systems both in aqueous and non aqueous 
media, and therefore they can act as carriers for important hydrophobic molecules such as drugs and 
nutraceutics.  
Certainly, a very large number of contributions have been reported on vitamin C, most of them dealing 
with the elaboration at positions 2, 3 or 6, depending on the application needs.
18-22
 Generally 6-O-ascorbyl 
esters are obtained via different methods, by reacting vitamin C and fatty acids under catalysis of lipases
20
 or 
in concentrated sulfuric acid.
23 
    
Here we report the preparation and full characterization of lipophilic saturated and unsaturated 5,6-O-
diesters of L-ASC, as well as of sulphur-containing 6-O-ascorbyl alkanoates. Preliminary evaluation of their 
antioxidant properties will also be described.  
 
 
Results and Discussion 
 
To the best of our knowledge, few examples of synthesis of 5,6-diesters of L-ASC have been reported. 
Nevertheless, a very large number of examples of esterification at C-6 with palmitoyl chloride were described 
in a patent, bearing different substituents and protecting groups on selected hydroxyls.
24
 Chemical 
modifications of vitamin C are often limited by its intrinsic instability. Typically, together with the methods 
cited above, the chemical synthesis of ascorbyl esters is carried out by selective protection and deprotection 
of functional groups. Several steps are required to obtain the target compounds. Usually the first step involves 
the protection of hydroxyl groups on C-6 and C-5 as an acetonide, followed by treatment of the enol hydroxyls 
with benzyl bromide.
21,25
 Nevertheless, on the basis of results recently reported
26 
and of our own results in 
separate experiments, we observed a high, selective reactivity of the ene-diol portion with benzyl bromide by 
comparison with the alcohols at the 5 and 6 positions. This allowed us to treat L-ASC 1 with BnBr and K2CO3 in 
THF/DMSO (Scheme 1) directly, thus avoiding preliminary protection as 5,6-O-isopropylidene derivative and 
the following deprotection step. 
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Scheme 1. (i) RBr/K2CO3, THF/DMSO, 50 °C, 3 h; (ii) acyl chlorides, 4-DMAP/DCC or Et3N (see experimental); 
(iii) H2, Pd/C or SnCI4/PhSH (see experimental). 
 
The dibenzyl ether 2a was then treated with saturated fatty acid derivatives. Thus acyl chlorides of 
octanoic (caprylic, C8), decanoic (capric, C10) and dodecanoic (lauric, C12) acid were reacted in the presence of 
DMAP/DCC in acetonitrile (Scheme 1). L-Ascorbyl 5,6-O-dialkanoates 3a-c were obtained in high yields (Table 
1, entries 1-3). Cleavage with H2, Pd/C led to the formation in quantitave yield of the previously unreported 
2,3-(OH)2-5,6-diesters 4a-c, which were fully characterized by means of NMR and MS spectra. 
 
Table 1. Synthesis of saturated and unsaturated L-ASC esters 
Entry R R
1
 R
2
 
Products 
(Yield %)
a
 
Products 4 
(Yield %)
a
 
1 Bn CH3(CH2)6 CO(CH2)6CH3 3a (90) 4a (>98) 
2 Bn CH3(CH2)8 CO(CH2)8CH3  3b (88) 4b (>98) 
3 Bn CH3(CH2)10 CO(CH2)10CH3 3c (91) 4c (>98) 
4 Bn CH3(CH2)10 COCH3   3d (63)
b
 4d (>98) 
5 Bn C17H33 cis-∆9 (CO)C17H33 cis-∆9 3e (78) - 
6 PMB C17H33 cis-∆9 (CO)C17H33 cis-∆9 3f (83) 4e (34) 
7 Bn CH=CH2 (CO)CHCH2 3g (75) - 
8 PMB C17H33 cis-∆9 H 5a (48) - 
9 Bn CH=CH2 H   5b (53)
c
 - 
10 PMB CH=CH2 H   5c (48)
c
 - 
11 Bn CH3(CH2)10 H 5d (68) - 
a
 Isolated yields. 
b
 Global yield over two steps. 
c
10% of diester was also formed. 
 
In order to synthesize derivatives with different acyl chain lengths, for evaluating the influence on physico-
chemical properties, compound 3d (Table 1, entry 4) was prepared in two steps from lauroyl- and acetyl-
chlorides (see experimental). The final deprotection afforded the mixed diester 4d (Scheme 1) . All the diesters 
were obtained with high selectivity (>99%), no trace of monoesters being observed. 
Our interest also focused in the preparation of ascorbyl oleates. These compounds bear, on the same 
molecular skeleton, both oleic and ascorbic acid residues, that each possess antioxidant properties. However, 
the synthesis was not straightforward, the products being rather sensitive compounds. This makes ascorbyl 
oleate difficult to produce with traditional chemical methods. To the best of our knowledge only one example 
has been described for ascorbyl 6-monooleate,
27  
while enzymatic methodologies are generally reported.
28-34 
The search for alternative methods is therefore a challenge to access these molecules.  
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Following a similar approach, oleoyl chloride was reacted with 2a leading to the formation of 2,3-O-
dibenzyl-5,6-O-ascorbyl dioleate 3e in good yield (Scheme 1 and Table 1, entry 5). For the cleavage of benzylic 
ethers, the incompatibility of H2, Pd/C system with the double bonds prompted us to seek alternative, mild 
methods. Unfortunately, treatment with CSI (chlorosulfonyl isocyanate)
35
 did not afford the desired 
compound, but a complex mixture of products was formed. Thus, a different protecting group – p-
methoxybenzyl (PMB) – was chosen. PMB can be more easily cleaved with numerous reagents, avoiding 
strong conditions.
36,37  
PMB-protected ascorbic acid 2b was prepared under the same conditions by direct 
treatment of  L-ASC with PMBBr/K2CO3 (Scheme 1). Subsequent reaction with oleyl chloride afforded 2,3-O-p-
methoxybenzyl-5,6-O-ascorbyl dioleate 3f (Scheme 1 and Table 1, entry 6) or 2,3-O-p-methoxybenzyl-6-O-
ascorbyl oleate 5a (Table 1, entry 8), depending on the reaction conditions (treatment with DMAP/DCC for 
diester, with Et3N for monoester). Efficient cleavage of 3f with SnCl4/thiophenol
37 
at -78 °C
 
 led to the isolation 
of the 2,3-deprotected ascorbyl dioleate 4e, while reaction on 5a allowed cleavage of only one PMBO-group 
(most likely on C-2). Further experiments are under investigation to obtain complete deprotection at both 
positions. Nonetheless, the result obtained is rather interesting, providing new ascorbyl oleates through a 
convenient, alternative access.    
As a further step, we decided to evaluate the esterification on the secondary OH at position 5, retaining a 
free hydroxyl at C-6. To achieve this, a preliminary protection of 6-OH with trityl chloride was carried out on 2a 
and 2b following literature procedures (Scheme 2).
25
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Scheme 2. (i) Trityl chloride/Et3N; (ii) R
1
COCl/DMAP/DCC; (iii) BF3
.
Et2O; iv) H2, Pd/C. 
 
After purification, the so obtained products 6a,b were reacted respectively with lauroyl chloride and oleoyl 
chloride in the presence of DMAP/DCC, leading to 7a and 7b in good yields (Scheme 2). Deprotection of 6-OTrt 
under acidic conditions
38 
was performed by treatment of 7a with BF3 etherate, leading to 8 (Scheme 2, via A). 
When reductive cleavage was carried out to obtain complete deprotection on C-2/C-3, a very complex mixture 
was observed, and the desired product 10 was present in only very low yield (<10%).  
In order to seek better conditions, we firstly considered deprotection of benzyl groups in 7a with H2/Pd/C 
(Scheme 2, via B). Compound 9 was isolated, and then treated under acidic conditions (BF3) to remove the 
trityl group. Unfortunately, through this sequence, compound 10 was also formed in comparable yields (ca. 
10%), and optimization of this step is surely required. 
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Scheme 3. (i) PhSH, Neutral Al2O3; (ii) HSCH2CH2SH, neutral Al2O3 (see experimental). 
 
Nevertheless, compound 9 is interesting, in so far as the enediol moiety, responsible of the antioxidant 
activity of vitamin C, is still present in this molecule. 
Finally, to introduce a sulfurated or selenated group on the skeleton of vitamin C, we prepared ascorbyl 
5,6-O-diacrylate 3g and 6-O-acrylates 5b,
24 
5c (Scheme 1 and Table 1, entries 3, 9 and 10). Then 5b, 5c and 3g 
were reacted respectively with one or two equivalents of a sulfur nucleophile (PhSH) in the presence of Al2O3
39 
(Scheme 3). Under these conditions compounds 11a, 11b and 12 were isolated, arising from a thio-Michael 
addition to the enones.  
Even more interesting was the reaction of 5b with 1,2-ethanedithiol, providing the synthesis of the 
diascorbyl derivative 13, containing a sulfurated linker between the two vitamin C moieties (Scheme 3). It will 
be of interest to investigate the characteristics of such derivatives, including chains of different length, to 
compare their properties with the behaviour of bolaform surfactants studied by some of us.
12
 Search for 
conditions to deprotect 2,3-positions is currently under study in our laboratory. 
Finally, in order to preliminary evaluate whether the antioxidant capacity was maintained for these new 
amphiphilic structures, they were tested through the DPPH assay,
40
 which provides an easy and rapid way to 
assess antioxidant potency. Substances 4a-e and 9 exhibited a very high ability to act as free radical 
scavengers, in fact they instantaneously reacted with DPPH. 
 
Conclusions 
 
Different saturated and unsaturated ascorbyl derivatives, including novel sulfurated compounds, were 
prepared from fatty acids, and characterized by mono- and bidimensional NMR experiments. Their antioxidant 
activity was determined with the DPPH assay.    
 
Experimental Section 
 
General. NMR spectra were recorded in CDCl3 with Varian Gemini 200, Mercury 400, Inova 400 and Bruker 
400 spectrometers operating at 200 and 400 MHz (
1
H), 50 and 100 MHz (
13
C). NMR signals were referenced to 
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non deuterated residual solvent signals of deuterochloroform (7.26 ppm for 
1
H, 77.0 ppm for 
13
C). Mass 
spectra (MS) were obtained by ESI. IR spectra were recorded on a Perkin Elmer Instrument (FT-IR). Only 
selected absorptions are reported, in wavenumbers (cm
-1
). Solvents were dried using a solvent purification 
system (Pure-Solv
TM
). Flash column chromatography was performed using silica gel (230-400 mesh). Where 
not specified, products were commercially available or obtained through reported procedures. 4-
Methoxybenzyl bromide (PMBBr) was synthesised from (4-methoxyphenyl)methanol (PMBOH) upon 
treatment with phosphorus tribromide.
41 
DPPH assay was performed according to the literature,
40
 by 
measuring the adsorbance decreasing of a DPPH methanolic solution (10
-4
 M) treated with an equimolar 
amount of ascorbic acid derivatives (4 a-e, 9).      
  
 
General procedure for the protection of L-ascorbic acid as 2,3-dibenzyl- or 2,3-bis(p-methoxybenzyl)-ethers 
(GP1)
25
  
Benzyl bromide or p-methoxybenzyl bromide (2.4 eq) was added to a suspension of L-ascorbic acid (1.0 eq) 
and K2CO3 (3.0 eq) in DMSO/THF (2:1 vol) and the reaction was stirred at 50 °C for 3 h. Afterwards, the mixture 
was filtered through a Celite pad and the organic phase was extracted with EtOAc and washed with brine and 
H2O. The organic layer was dried on Na2SO4, filtered and the solvent was removed under reduced pressure. 
The crude material was purified by flash chromatography (petroleum ether/EtOAc). 
(R)-5-((S)-1,2-Dihydroxyethyl)-3,4-bis((4-methoxybenzyl)oxy)furan-2(5H)-one (2b). Following the general 
procedure, 1.8 g of L-ascorbic acid and 4.94 g of p-methoxybenzyl bromide gave, after purification, 2b (1.91 g, 
45%) as yellowish oil. 
1
H NMR (400 MHz, CDCl3): δ (ppm) 3.80 (s, 3H), 3.81 (s, 3H), 3.71-3.81 (m, 2H), 3.85-3.90 
(m, 1H), 4.64 (d, J 2.4 Hz, 1H, CHO), 5.06 (ap s, 2H), 5.07 (d, J 11.2 Hz, 1H), 5.12 (d, J 11.2 Hz, 1H), 6.86 (ap d, ls 
8.6 Hz, 2H), 6.91 (ap d, ls 8.6 Hz, 2H), 7.15 (ap d, ls 8.6 Hz, 2H), 7.33 (ap d, ls 8.6 Hz, 2H). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) 55.3, 63.3, 69.9, 73.4, 73.7, 76.1, 113.9, 114.0, 120.8, 127.3, 128.1, 129.9, 130.9, 157.6, 159.9, 
160.0, 170.1. Elemental Analysis: C22H24O8 C 63.45%, H 5.81%. Found: C 63.22%, H 5.83%. 
General procedure for the synthesis of ascorbyl 5-O-,6-O-dialkanoates protected as 2,3-dibenzyl ethers or 
2,3-bis((4-methoxybenzyl) ethers. (GP2). 4-DMAP (12 mmol, 3 eq.) and DCC (12 mmol, 3 eq.) were added to a 
stirred solution of 2a or 2b (4 mmol, 1 eq.) in MeCN (40 mL) under inert atmosphere at rt. Then the alkanoyl 
chloride (9.2 mmol, 2.3 eq.) was slowly added and the mixture was stirred for 12 h. Afterwards the solvent 
was removed under reduced pressure and the crude material purified by flash chromatography (petroleum 
ether/EtOAc 8:1). 
(S)-1-((R)-3,4-Bis(benzyloxy)-5-oxo-2,5-dihydrofuran-2-yl)ethane-1,2-diyl dioctanoate (3a). Following the 
general procedure GP2, 2a (1.0 g, 2.80 mmol) and octanoyl chloride (1.043 g, 6.44 mmol) gave, after flash 
chromatography, 3a (1.53 g, 90%) as a colourless oil. 
1
H NMR (200 MHz, CDCl3): δ (ppm) 0.82-0.89 (m, 6H), 
1.18-1.27 (m, 16H), 1.43-1.54 (m, 4H), 2.15-2.33 (m, 4H), 4.22 (dd, J 7.4, 11.6 Hz, 1H, CHaHbO), 4.33 (dd, J 5.6, 
11.6 Hz, 1H, CHaHbO), 4.80 (d, J 2.2 Hz, 1H, CHO), 5.10 (ap. s, 2H, CH2Ph), 5.15 (ap. s, 2H, CH2Ph), 5.34-5.42 (m, 
1H, CHCH2), 7.19-7.25 (m, 4H), 7.27-7.42 (m, 6H). 
13
C NMR (50 MHz, CDCl3): δ (ppm) 13.9, 22.5, 24.6, 24.7, 
24.8, 28.7, 28.8, 28.9, 31.5, 33.8, 61.8, 67.3, 73.5, 73.6, 121.2, 127.9, 128.0, 128.6, 128.7, 128.8, 128.9, 129.0, 
135.0, 135.9, 154.9, 168.3, 172.1, 172.8. MS (ESI positive) m/z (%): 632 [M+Na]
+
, (100). Elemental Analysis: 
C36H48O8 C 71.03%, H 7.95%. Found: C 70.82%, H 7.98%. 
(S)-1-((R)-3,4-Bis(benzyloxy)-5-oxo-2,5-dihydrofuran-2-yl)ethane-1,2-diyl didecanoate (3b). Following the 
general procedure GP2, 2a (1.0 g, 2.80 mmol) and decanoyl chloride (1.22 g, 6.44 mmol) gave, after flash 
chromatography, 3b (1.64 g, 88%) as a colourless oil. 
1
H NMR (400 MHz, CDCl3): δ (ppm) 0.84-0.90 (m, 6H), 
1.25 (m, 24H), 1.52-1.66 (m, 4H), 2.19 (dt, J 2.2, 7.1 Hz, 2H), 2.22-2.33 (m, 2H), 4.22 (dd, J 7.0, 11.7 Hz, 1H, 
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CHaHbO), 4.32 (dd, J 5.9, 11.7 Hz, 1H, CHaHbO), 4.80 (d, J2.0 Hz, 1H, CCHO), 5.10 (ap s, 2H, CH2Ph), 5.14 (ap s, 
2H, CH2Ph), 5.35-5.39 (m, 1H, CHCH2), 7.21-7.23 (m, 2H), 7.33-7.39 (m, 8H). 
13
C NMR (50 MHz, CDCl3): δ (ppm) 
13.7, 22.3, 24.3, 24.5, 24.7, 25.2, 28.8, 28.9, 29.1, 31.6, 33.6, 34.6, 55.3, 61.6, 67.2, 73.3, 73.5, 121.2, 127.7, 
128.3, 128.4, 134.9, 135.7, 154.7, 168.1, 171.7, 172.5. MS (ESI positive) m/z (%): 687 [M+Na]
+
, (100). Elemental 
Analysis: C40H56O8 C 72.26%, H 8.49%. Found: C 72.01%, H 8.52%. 
(S)-1-((R)-3,4-Bis(benzyloxy)-5-oxo-2,5-dihydrofuran-2-yl)ethane-1,2-diyl didodecanoate (3c). Following the 
general procedure GP2, 2a (1.41 g, 3.95 mmol) and dodecanoyl chloride (1.981 g, 9.1 mmol) gave, after flash 
chromatography, 3c (2.59 g, 91%) as a colourless oil. 
1
H NMR (200 MHz, CDCl3): δ (ppm) 0.84-0.90 (m, 6H), 
1.24 (m, 32H), 1.48-1.53 (m, 4H), 2.14-2.26 (m, 4H), 3.83 (ap d, ls 6.2 Hz, 2H, CH2O), 4.90 (d, J 1.8 Hz, 1H, 
CCHO), 5.10 (ap s, 2H, CH2Ph), 5.17 (ap.s, 2H, CH2Ph ), 5.18-5.23 (m, 1H, CHCH2), 7.17-7.28 (m, 2H), 7.33-7.41 
(m, 8H). 
13
C NMR (50 MHz, CDCl3): δ (ppm) 14.0, 22.7, 24.8, 25.0, 29.1, 29.3, 29.4, 29.6, 31.9, 34.0, 61.9, 67.5, 
73.8, 121.6, 128.0, 128.7, 128.8, 128.9, 135.2, 136.0, 155.1, 168.5, 172.2, 173.0. MS (ESI positive) m/z (%): 744 
[M+Na]
+
, (100). Elemental Analysis: C44H64O8 C 73.30%, H 8.95%. Found: C 73.46%, H 8.92%. 
(S)-2-Acetoxy-2-((R)-3,4-bis(benzyloxy)-5-oxo-2,5-dihydrofuran-2-yl)ethyl dodecanoate (3d). Acetyl chloride 
(154 mg, 1.95 mmol, 1.5 eq.) was slowly added, to a cooled solution (0 °C) of 5d (vide infra) (700 mg, 1.30 
mmol, 1.0 eq.) and Et3N (400 mg, 3.9 mmol, 3.0 eq.) in CH2Cl2 (10 mL). The reaction was allowed to warm up 
to rt and the mixture was stirred overnight under inert atmosphere. The reaction was then diluted with H2O 
(10 mL), the layers separated and the aqueous layer extracted into Et2O (2 x 10 mL). The combined organic 
layers were dried over Na2SO4, filtered, concentrated in vacuo and purified by flash column chromatography 
(petroleum ether/EtOAc 4:1) to give 3d (695 mg, 92%) as a colourless oil. 
1
H NMR (200 MHz, CDCl3): δ (ppm) 
0.87 (ap t, J 7.0 Hz, 3H), 1.24 (m, 16H), 1.42-1.63 (m, 2H), 1.93 (s, 3H), 2.27 (t, J 8 Hz, 2H), 4.25 (dd, J 7.3, 12.0 
Hz, 1H, CHaHbO), 4.32 (dd, J 6.6, 12.0 Hz, 1H, CHaHbO), 4.80 (d, J 2.2 Hz, 1H, CHO), 5.06-5.13 (m, 2H), 5.15 (ap. 
s, 2H, CH2Ph), 5.26-5.39 (m, 1H), 7.17-7.26 (m, 2H), 7.33-7.40 (m, 8H). 
13
C NMR (50 MHz, CDCl3): δ (ppm) 14.1, 
20.4, 22.6, 24.7, 29.1, 29.2, 29.3, 29.4, 29.6, 31.9, 33.9, 61.8, 67.7, 73.7, 121.4, 128.0, 128.4, 128.8, 129.0, 
135.1, 135.9, 155.1, 168.5, 169.4, 173.0. MS (ESI positive) m/z (%): 603 [M+Na]
+
, (100). Elemental Analysis: 
C34H44O8 C 70.32%, H 7.64%. Found: C 70.08%, H 7.67%. 
(S)-1-((R)-3,4-Bis(benzyloxy)-5-oxo-2,5-dihydrofuran-2-yl)ethane-1,2-diyl dioleate (3e). Following the general 
procedure GP2, 2a (500 mg, 1.40 mmol) and oleoyl chloride (969 mg, 3.22 mmol) gave, after flash 
chromatography, 3e (966 mg, 78%) as a slightly yellowish oil. 
1
H NMR (200 MHz, CDCl3): δ (ppm) 0.88 (ap t, J 
6.4 Hz, 6H), 1.17-1.40 (m, 40H), 1.48-1.68 (m, 4H), 1.93-2.08 (m, 8H), 2.18-2.31 (m, 4H), 4.23 (dd, J 7.1, 11.5 
Hz, 1H, CHaHbO), 4.34 (dd, J 5.0, 11.5 Hz, 1H, CHaHbO), 4.80 (d, J 2.1 Hz, 1H, CHO), 5.11 (s, 2H), 5.16 (s, 2H), 
5.26-5.44 (m, 5H), 7.21-7.43 (m, 10H). 
13
C NMR (50 MHz, CDCl3): δ (ppm) 14.0, 22.6, 24.8, 25.0, 27.2, 29.1, 
29.3, 29.5, 29.7, 29.8, 31.9, 34.0, 61.9, 67.6, 73.7, 121.7, 128.0, 128.2, 128.7, 128.8, 128.9, 129.7, 130.0, 135.2, 
136.1, 155.0, 168.4, 172.1, 172.9. MS (ESI positive) m/z (%): 908 [M+Na]
+
, (100). Elemental Analysis: C56H84O8 C 
75.98%, H 9.56%. Found: C 75.77%, H 9.58%. 
(S)-1-((R)-3,4-Bis((4-methoxybenzyl)oxy)-5-oxo-2,5-dihydrofuran-2-yl)ethane-1,2-diyl dioleate (3f). Following 
the general procedure GP2, 2b (200 mg, 0.48 mmol) and oleoyl chloride (301 mg, 1.0 mmol) gave, after flash 
chromatography, 3f (376 mg, 83%) as a slightly yellowish oil. 
1
H NMR (200 MHz, CDCl3): δ (ppm) 0.83-0.91 (m, 
6H), 1.19-1.29 (m, 40H), 1.41-1.66 (m, 4H), 1.87-2.05 (m, 8H), 2.17-2.36 (m, 4H), 3.78 (s, 3H), 3.79 (s, 3H), 4.19 
(dd, J 7.3, 11.7 Hz, 1H, CHaHbO), 4.31 (dd, J 5.5, 11.7 Hz, 1H, CHaHbO) 4.75 (d, J 2.2 Hz, 1H, CHO), 5.06 (ap. s, 
4H, CH2Ar), 5.27-5.38 (m, 5H), 6.83-6.91 (m, 4H), 7.17 (ap d, ls 8.8 Hz, 2H), 7.32 (ap d, ls 8.8 Hz, 2H). 
13
C NMR 
(50 MHz, CDCl3): δ (ppm) 14.0, 22.6, 24.7, 24.9, 27.1, 29.0, 29.1, 29.2, 29.5, 29.6, 29.7, 31.8, 33.9, 55.2, 61.8, 
67.4, 73.3, 73.4, 73.7, 114.0, 121.2, 127.2, 128.1, 129.6, 129.9, 130.6, 155.2, 160.0, 168.6, 172.1, 172.9. MS 
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(ESI positive) m/z (%): 968 [M+Na]
+
, (100). Elemental Analysis: C58H88O10 C 73.69%, H 9.38%. Found: C 73.91%, 
H 9.40%. 
(S)-1-((R)-3,4-Bis(benzyloxy)-5-oxo-2,5-dihydrofuran-2-yl)ethane-1,2-diyl diacrylate (3g). Following the 
general procedure GP2, 2a (200 mg, 0.56 mmol) and acryloyl chloride (117 mg, 1.29 mmol) gave, after flash 
chromatography, 3g (195 mg, 75%) as a colourless oil. 
1
H NMR (200 MHz, CDCl3): δ (ppm) 4.36-4.45 (m, 2H, 
CH2O), 4.87 (d, J 2.2 Hz, 1H, CHO), 5.06 (d, J 10.2, 1H, CH2Ph), 5.08 (ap. s, 2H, CH2Ph), 5.14 (d, J 10.2, 1H, 
CH2Ph), 5.42-5.56 (m, 1H), 5.81-6.19 (m, 4H), 6.37-6.51 (m, 2H), 7.19-7.38 (m, 10H). 
13
C NMR (50 MHz, CDCl3): 
δ (ppm) 62.0, 67.6, 73.6, 73.7, 73.9, 121.7, 127.9, 127.2, 127.5, 128.0, 128.6, 128.7, 128.9, 131.8, 132.5, 134.9, 
135.8, 155.2, 164.3, 165.2, 168.6. MS (ESI positive) m/z (%): 487 [M+Na]
+
, (100). Elemental Analysis: C26H24O8 C 
67.23%, H 5.21%. Found: C 67.13%, H 5.22%. 
Cleavage of benzyl ethers. General procedure (GP3). To a solution of ascorbyl 5-O-,6-O-dialkanoate-2,3-
dibenzyl ethers 3a-d (3.0 mmol) in EtOAc (30 mL), Pd/C (10%) was added. Then a balloon filled with H2 was 
attached to the flask and the reaction was stirred for 2 h. The reaction progress was monitored by TLC. After 
the complete consumption of the starting product, the mixture was filtered through Celite and the solvent was 
removed under reduced pressure. Crystallization from Et2O/petroleum ether gave ascorbyl 5-O-,6-O-
dialkanoates 4a-d in almost quantitative yield.  
(S)-1-((R)-3,4-Dihydroxy-5-oxo-2,5-dihydrofuran-2-yl)ethane-1,2-diyl dioctanoate (4a). Prepared from 3a 
according to the general procedure GP3. White solid. 
1
H NMR (200 MHz, CDCl3): δ (ppm) 0.84-0.90 (m, 6H), 
1.22-1.29 (m, 16H), 1.51-1.67 (m, 4H), 2.28-2.36 (m, 4H), 4.29 (dd, J 6.6, 11.8 Hz, 1H, CHaHbO), 4.42 (dd, J 4.8, 
11.8.0 Hz, 1H, CHaHbO), 4.91 (d, J 3.4 Hz, 1H, CHO), 5.38-5.46 (1H, m, CHO). 
13
C NMR (100 MHz, CDCl3): δ 
(ppm) 13.9, 22.5, 24.7, 24.8, 28.8, 28.9, 29.0, 31.5, 34.0, 62.0, 68.2, 74.6, 119.5, 148.9, 170.1, 172.9, 173.7. 
Elemental Analysis: C22H36O8 C 61.66%, H 8.47%. Found: C 61.59%, H 8.50%. 
(S)-1-((R)-3,4-Dihydroxy-5-oxo-2,5-dihydrofuran-2-yl)ethane-1,2-diyl didecanoate (4b). Prepared from 3b 
according to the general procedure GP3. White solid. 
1
H NMR (400 MHz, CDCl3): δ (ppm) 0.87 (ap t, ls 6.6 Hz, 
6H), 1.26 (m, 24H), 1.51-1.68 (m, 4H), 2.29-2.38 (m, 4H), 4.30 (dd, J 6.8, 11.6 Hz, 1H, CHaHbO), 4.42 (dd, J 4.8, 
11.6 Hz, 1H, CHaHbO), 4.92 (d, J 3.6 Hz, 1H, CHO), 5.41-5.45 (m, 1H, CHCH2). 
13
C NMR (50 MHz, CDCl3): δ (ppm) 
13.9, 22.5, 24.6, 24.7, 28.9, 29.0, 29.1, 29.3, 31.7, 33.9, 34.0, 62.1, 68.1, 74.8, 119.1, 150.9, 171.5, 173.1, 173.9 
ppm. MS (ESI negative) m/z (%): 483 [M-H]
–
, (100). IR [CDCl3] ν (cm
-1
): 3350-3400, 3100-3200, 2800-2950, 
1550, 1690, 1620, 1100-1200. Elemental Analysis: C26H44O8 C 64.44%, H 9.15%. Found: C 64.09%, H 9.25%. 
(S)-1-((R)-3,4-Dihydroxy-5-oxo-2,5-dihydrofuran-2-yl)ethane-1,2-diyl didodecanoate (4c). Prepared from 3c 
according to the general procedure GP3. White solid 
1
H NMR (400 MHz, CDCl3): δ (ppm) 0.88 (m, 6H), 1.26 (m, 
32H), 1.54-1.65 (m, 4H), 2.29-2.34 (m, 4H), 4.31 (dd, J 6.6, 11.7 Hz, 1H, CHaHbO), 4.41 (dd, J 4.8, 11.7 Hz, 1H, 
CHaHbO), 4.90 (d, J 3.1 Hz, 1H, CHO), 5.38-5.43 (m, 1H, CHCH2). 
13
C NMR (100 MHz, CDCl3): δ (ppm) 13.9, 22.5, 
24.6, 24.7, 28.9, 29.0, 29.2, 29.4, 29.5, 31.8, 33.8, 33.9, 62.1, 68.1, 74.7, 118.8, 151.4, 171.5, 173.0, 173.8. MS 
(ESI negative) m/z (%): 539 [M-H]
–
, (100). IR [CDCl3] ν (cm
-1
): 3300-3500, 2800-2950, 1770, 1690, 1100-1190. 
Elemental Analysis: C30H52O8 C 64.64%, H 9.69%. Found C 64.32%, H 9.59%. 
(S)-2-Acetoxy-2-((R)-3,4-dihydroxy-5-oxo-2,5-dihydrofuran-2-yl)ethyl dodecanoate (4d). Prepared from 3d 
according to the general procedure GP3. White solid 
1
H NMR (400 MHz, CDCl3): δ (ppm) 0.87 (t, J 6.8 Hz, 3H), 
1.19-1.38 (m, 16H), 1.54-1.69 (m, 2H), 2.09 (s, 3H), 2.34 (t, J 7.6Hz, 2H), 4.31 (dd, J 6.6, 11.8 Hz, 1H, CHaHbO), 
4.42 (dd, J 4.8, 11.8 Hz, 1H, CHaHbO), 4.95 (d, J 3.5 Hz, 1H, CHO), 5.38-5.46 (1H, m, CHO). 
13
C NMR (100 MHz, 
CDCl3): δ (ppm) 14.1, 20.6, 22.7, 24.8, 29.1, 29.2, 29.3, 29.4, 29.6, 31.9, 34.0, 61.9, 68.5, 74.7, 119.2, 150.4, 
170.4, 171.3, 173.9. MS (ESI negative) m/z (%): 399 [M-H]
–
, (100). Elemental Analysis: C20H32O8 C 59.98%, H 
8.05%. Found C 59.63%, H 8.19%. 
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(S)-1-((R)-3,4-Dihydroxy-5-oxo-2,5-dihydrofuran-2-yl)ethane-1,2-diyl dioleate (4e). To a solution of 3f (155 
mg, 0.16 mmol, 1 eq.) and benzenethiol (43 mg, 0.38 mmol, 2.4 eq.) in dry CH2Cl2 (3 mL) cooled at -78 °C, SnCl4 
(39.4 mL, 0.336 mmol, 2.1 eq.) was dropwise added and the reaction was stirred for 30 min. Then the mixture 
was quenched with saturated aqueous NaHCO3, allowed to warm up at rt and extracted with EtOAc, dried 
over Na2SO4, filtered and concentrated in vacuo. The residue was purified by column chromatography 
(petroleum ether/EtOAc 1:1) to give 4e (38 mg, 34%) as a slightly yellow sticky solid. 
1
H NMR (200 MHz, 
CDCl3): δ (ppm) 0.83-0.95 (m, 6H), 1.21-1.32 (m, 40H), 1.46-1.63 (m, 4H), 1.93-2.04 (m, 8H), 2.24-2.36 (m, 4H), 
4.27 (dd, J 6.6, 11.9 Hz, 1H, CHaHbO), 4.41 (dd, J 5.0, 11.9 Hz, 1H, CHaHbO), 4.89 (d, J 2.6 Hz, 1H, CHO), 5.31-
5.36 (m, 4H), 5.37-5.47 (m, 1H). 
13
C NMR (50 MHz, CDCl3): δ (ppm) 13.8, 22.6, 24.8, 24.8, 27.0, 29.0, 29.1, 29.3, 
29.4, 29.6, 29.7, 31.9, 34.2, 61.8, 67.4, 73.5, 129.7, 130.0, 155.3, 168.9, 172.6, 173.8. MS (ESI negative) m/z 
(%): 704 [M-H]
-
, (100). Elemental Analysis: C42H72O8 C 71.55%, H 10.29%. Found: C 71.38%, H 10.31%. 
(S)-2-((R)-3,4-Bis((4-methoxybenzyl)oxy)-5-oxo-2,5-dihydrofuran-2-yl)-2-hydroxyethyl oleate (5a). Oleoyl 
chloride (331 mg, 1.1 mmol) was slowly added to a solution of 2b (416 mg, 1.0 mmol) and Et3N (507 mg, 5.0 
mmol) in CH2Cl2 (10 mL). The reaction was stirred overnight under inert atmosphere at ambient temperature. 
Afterwards, the mixture was diluted with H2O (10 mL) and the aqueous layer extracted into Et2O (2 x 10 mL). 
The combined organic layers were dried over Na2SO4, filtered, concentrated in vacuo and purified by flash 
column chromatography (petroleum ether/EtOAc 4:1) to give the product 5a (327 mg, 48%). Colourless oil 
1
H 
NMR (200 MHz, CDCl3): δ (ppm) 0.83-0.91 (m, 3H), 1.19-1.29 (m, 20H), 1.47-1.61 (m, 2H), 1.87-2.11 (m, 4H), 
2.17-2.35 (m, 2H), 3.79 (s, 3H), 3.81 (s, 3H), 4.02-4.36 (m, 3H), 4.62 (d, J 2.2 Hz, 1H, CHO), 5.07 (ap. s, 4H), 5.29-
5.36 (m, 2H), 6.84-6.91 (m, 4H), 7.17 (ap d, ls 8.8 Hz, 2H), 7.32 (ap d, ls 8.8 Hz, 2H). MS (ESI positive) m/z (%): 
704 [M+Na]
+
, (100). Elemental Analysis: C40H56O9 C 70.56 %, H 8.29%. Found: C 70.69%, H 8.30%. 
(S)-2-((R)-3,4-Bis(benzyloxy)-5-oxo-2,5-dihydrofuran-2-yl)-2-hydroxyethyl acrylate (5b). Acryloyl chloride 
(99.6 mg, 1.1 mmol) was slowly added to a solution of 2a (356 mg, 1.0 mmol) and Et3N (152 mg, 1.5 mmol) in 
CH2Cl2 (10 mL). The reaction was stirred overnight under inert atmosphere at ambient temperature. 
Afterwards, the mixture was diluted with H2O (10 mL), the layers separated and the aqueous layer extracted 
into Et2O (2 x 10 mL). The combined organic layers were dried over Na2SO4, filtered, concentrated in vacuo 
and purified by flash column chromatography (petroleum ether/EtOAc 3:1) to give the product 5b (218 mg, 
53%) as a colourless oil. 
1
H NMR (200 MHz, CDCl3): δ (ppm) 2.10 (bs, 1H), 3.70-4.18 (m, 1H, CHCH2), 4.30 (dd, J 
5.1, 11.7 Hz, 1H, CHaHbO), 4.40 (dd, J 6.6, 11.7 Hz, 1H, CHaHbO), 4.69 (d, J 2.2 Hz, 1H, CHO), 5.10 (ap. s, 2H, 
CH2Ph), 5.13 (d, J 10.6, 1H, CH2Ph), 5.22 (d, J 10.6, 1H, CH2Ph), 5.87 (dd, 1H, J 1.5, 10.3 Hz), 6.13 (dd, 1H, J 10.3, 
17.2 Hz), 6.45 (dd, 1H, J 1.8, 17.2 Hz), 7.19-7.26 (m, 4H), 7.33-7.41 (m, 6H). 
13
C NMR (50 MHz, CDCl3): δ (ppm) 
64.9, 67.9, 73.6, 73.9, 75.4, 121.7, 127.9, 128.7, 128.8, 129.1, 131.8, 135.2, 135.9, 156.5, 165.9, 169.3. MS (ESI 
positive) m/z (%): 433 [M+Na]
+
, (100). Elemental Analysis: C23H22O7 C 67.31%, H 5.40%. Found: C 67.21%, H 
5.41%. 
(S)-2-((R)-3,4-Bis((4-methoxybenzyl)oxy)-5-oxo-2,5-dihydrofuran-2-yl)-2-hydroxyethyl acrylate (5c). 
Following the same procedure as described above for 5b, acryloyl chloride (72 mg, 0.79 mmol) and 2b (300 
mg, 0.72 mmol) gave, after purification by column chromatography (petroleum ether/EtOAc 2:1), 5c (162 mg, 
48%). Colourless oil. 
1
H NMR (200 MHz, CDCl3): δ (ppm) 2.20 (bs, 1H), 3.79 (s, 3H), 3.81 (s, 3H), 4.03-4.12 (m, 
1H, CHCH2), 4.22 (dd, J 5.4, 11.4 Hz, 1H, CHaHbO), 4.37 (dd, J 6.8, 11.4 Hz, 1H, CHaHbO), 4.65 (d, J 2.2 Hz, 1H, 
CHO), 5.02 (d, J 12.2, 1H), 5.05 (ap. s, 2H), 5.12 (d, J 12.2, 1H), 5.85 (dd, 1H, J 1.8, 10.6 Hz), 6.11 (dd, 1H, J 10.4, 
17.2 Hz), 6.42 (dd, 1H, J 1.8, 17.2 Hz), 6.82-6.91 (m, 4H), 7.14 (ap d, ls 7.14 Hz, 2H), 7.32 (ap d, ls 7.14 Hz, 2H). 
Elemental Analysis: C25H26O9 C 63.82%, H 5.57%. Found: C 63.73%, H 5.58%. 
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(S)-2-((R)-3,4-Bis(benzyloxy)-5-oxo-2,5-dihydrofuran-2-yl)-2-hydroxyethyl dodecanoate (5d). Following the 
same procedure as described for 5a, dodecanoyl chloride (0.90 g, 4.14 mmol), 2a (1.34 g, 3.76 mmol) and Et3N 
(1.90 g, 18.8 mmol) gave, after purification by column chromatography (petroleum ether/EtOAc 3:1), 5d (1.38 
g, 68%) as a colourless oil. 
1
H NMR (200 MHz, CDCl3): δ (ppm) 0.88 (ap t, J 7.2 Hz, 3H), 1.25 (m, 16H), 1.48-1.61 
(m, 2H), 2.33 (t, J 8 Hz, 2H), 4.01-4.11 (m, 1H), 4.21 (dd, J 5.0, 11.9 Hz, 1H, CHaHbO), 4.36 (dd, J 6.2, 11.9 Hz, 1H, 
CHaHbO), 4.67 (d, J 1.8 Hz, 1H, CHO), 5.11 (ap. s, 2H, CH2Ph), 5.11 (d, J 11.9, 1H, CH2Ph), 5.22 (d, J 11.9, 1H, 
CH2Ph), 7.18-7.26 (m, 2H), 7.33-7.41 (m, 8H). 
13
C NMR (50 MHz, CDCl3): δ (ppm) 14.0, 22.5, 24.8, 29.0, 29.1, 
29.3, 29.4, 29.5, 31.6, 34.0, 64.1, 67.6, 73.1, 73.8, 75.7, 121.3, 127.8, 128.2, 128.4, 128.7, 135.1, 135.6, 156.8, 
169.7, 173.5. Elemental Analysis: C32H42O7 C 71.35%, H 7.86%. Found: C 71.13%, H 7.93%. 
(S)-1-((R)-3,4-Bis(benzyloxy)-5-oxo-2,5-dihydrofuran-2-yl)-2-(trityloxy)-ethyl-dodecanoate (7a). Dodecanoyl 
chloride (279 mg, 1.28 mmol) was slowly added to a solution of (R)-3,4-bis(benzyloxy)-5-((S)-1-hydroxy-2-
(trityloxy)ethyl)furan-2(5H)-one 6a
24
 (700 mg, 1.16 mmol), 4-DMAP (212 mg, 1.74 mmol) and DCC (358 mg, 
1.74 mmol) in MeCN (13 mL). The reaction mixture was stirred for 18 h at rt under an inert atmosphere. The 
solvent was removed under reduced pressure and the crude material was purified by column chromatography 
(petroleum ether/EtOAc 8:1) to give 7a (842 mg, 93%). Colourless oil. 
1
H NMR (200 MHz, CDCl3) δ (ppm): 0.88 
(ap t, ls 6.5 Hz, 3H), 1.20-1.25 (m, 16H), 1.43-1.66 (m, 2H), 2.16-2.23 (m, 2H), 3.31 (dd, J 7.0, 9.5 Hz, 1H), 3.44 
(dd, J 7.0, 9.5 Hz, 1H), 4.90 (d, J 1.8 Hz, 1H), 5.07 (s, 2H), 5.14 (s, 2H), 5.23-5.31 (m, 1H), 7.19-7.43 (m, 25H). 
13
C 
NMR (50 MHz, CDCl3) δ (ppm): 14.0, 22.6, 24.9, 29.1, 29.2, 29.3, 29.5, 31.8, 34.0, 61.9, 68.6, 73.7, 73.9, 87.3, 
121.5, 127.1, 127.8, 128.0, 128.6, 128.7, 135.3, 136.1, 143.6, 155.5, 168.7, 172.1. MS (ESI positive) m/z (%): 
433 [M+Na]
+
, (100). Elemental Analysis: C51H56O7 C 78.43%, H 7.23%. Found: C 78.68%, H 7.20%. 
(S)-1-((R)-3,4-bis((4-methoxybenzyl)oxy)-5-oxo-2,5-dihydrofuran-2-yl)-2-(trityloxy)ethyl oleate (7b). 
Following the same procedure for the synthesis of 7a, oleoyl chloride (166 mg, 0.55 mmol) and 6b (329 mg, 
0.50) gave, after purification by column chromatography (petroleum ether/EtOAc 8:1), product 7b (402 mg, 
87%). Colourless oil. 
1
H NMR (400 MHz, CDCl3) δ (ppm): 0.82 (t, J 6.8 Hz, 3H), 1.15-1.25 (m, 20H), 1.41-1.56 (m, 
2H), 1.84-1.95 (m, 4H), 2.10-2.18 (m, 2H), 3.25 (dd, J 6.8, 10.0 Hz, 1H), 3.38 (dd, J 6.4, 10.0 Hz, 1H), 3.79 (s, 3H), 
3.81 (s, 3H), 4.84 (d, J 2.0 Hz, 1H), 5.02 (s, 2H), 5.06-5.10 (m, 2H), 5.18-5.22 (m, 1H), 5.23-5.31 (m, 2H), 6.87 (ap 
d, ls 8.8 Hz, 2H), 6.89 (ap d, ls 8.8 Hz, 2H), 7.20-7.44 (m, 19H). 
13
C NMR (50 MHz, CDCl3) 14.0, 22.6, 25.0, 27.2, 
29.1, 29.3, 29.5, 29.7, 29.8, 30.8, 31.9, 34.0, 34.1, 55.6, 61.4, 68.7, 70.6, 73.7, 73.8, 87.3, 113.8, 114.0, 121.6, 
127.1, 127.4, 127.8, 128.2, 128.7, 130.0, 130.9, 160.0, 143.7, 129.7, 130.0, 155.6, 172.2, 172.8. Elemental 
Analysis: C59H70O9 C 76.76%, H 7.64%. Found: C 76.59%, H 7.67%. 
(S)-1-((R)-3,4-bis(benzyloxy)-5-oxo-2,5-dihydrofuran-2-yl)-2-hydroxyethyl dodecanoate (8). A solution of 7a 
(156 mg, 0.2 mmol, 1 eq.) in dry CH2Cl2 (2 mL) was cooled at 0 °C, then BF3
.
Et2O (115 mL, 1.0 mmol, 5.0 eq.) 
was slowly added and the solution was stirred under an inert atmosphere for 1 h. Afterwards, a saturated 
aqueous solution of NaHCO3 (3 mL) was added and the mixture was extracted with CHCl3 (3 x 5 mL). The 
organic layers were dried on Na2SO4, filtered and the solvent was eliminated under reduced pressure. The 
crude material was purified by column chromatography (petroleum ether/EtOAc 8:1) affording 8 (79 mg, 73%) 
as a colourless oil. 
1
H NMR (200 MHz, CDCl3) δ (ppm): 0.89 (ap t, J 6.3 Hz, 3H), 1.20-1.29 (m, 16H), 1.45-1.65 
(m, 2H), 2.15-2.28 (m, 2H), 2.95 (bs, 1H, OH), 3.80 (ap d, ls 6.5 Hz, 2H, CH2O), 4.91 (d, J 1.8 Hz, 1H), 5.09 (s, 2H), 
5.18 (s, 2H), 5.14-5.24 (m, 1H), 7.21-7.29 (m, 2H), 7.31-7.41 (m, 8H). 
13
C NMR (50 MHz, CDCl3) δ (ppm): 13.9, 
22.5, 24.8, 29.0, 29.1, 29.2, 29.3, 29.4, 31.8, 33.9, 60.7, 70.1, 73.5, 73.7, 121.3, 127.1, 127.8, 128.5, 128.7, 
135.2, 136.0, 155.8, 168.9, 172.7. Elemental Analysis: C32H42O7 C 71.35%, H 7.86%. Found: C 71.13%, H 7.89%. 
(S)-1-((R)-3,4-dihydroxy-5-oxo-2,5-dihydrofuran-2-yl)-2-(trityloxy)ethyl dodecanoate (9). Prepared according 
to the general procedure GP3 starting from 7a (250 mg, 0.32 mmol). Purification by column chromatography 
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(CH2Cl2/MeOH 10:1) gave the product 9 (168 mg, 52%). 
1
H NMR (200 MHz, CDCl3) δ (ppm): 0.88 (ap t, J 6.2 Hz, 
3H), 1.17-1.34 (m, 16H), 1.50-1.66 (m, 2H), 2.21-2.28 (m, 2H), 3.34 (dd, J 5.9, 9.4 Hz), 3.46 (dd, J 6.6, 9.4 Hz), 
4.91 (d, J 2.7 Hz, 1H), 5.39-5.45 (m, 1H), 7.20-7.44 (m, 15H). 
13
C NMR (50 MHz, CDCl3) δ (ppm): 14.0, 22.5, 24.5, 
24.9, 25.4, 29.1, 29.3, 29.4, 31.7, 33.9, 34.8, 61.8, 68.5, 73.5, 87.2, 121.3, 127.0, 127.8, 127.9, 128.5, 128.7, 
135.2, 136.0, 143.4, 155.4, 168.2, 172.0. MS (ESI negative) m/z (%): 599 [M-H]
-
, (100). Elemental Analysis: 
C37H44O7 C 73.98%, H 7.38%. Found: C 73.72%, H 7.41%. 
General procedure for the thiol-Michael addition on ascorbyl acrylates (GP4). Neutral alumina was added to 
a solution of thiol (benzenethiol or 1,2-ethanedithiol) and ascorbyl acrylate 3b, 5b or 5c in dry toluene.
39 
The 
reaction was stirred under inert atmosphere at rt for 4 h. Afterwards the mixture was diluted with EtOAc, 
washed with H2O, dried over Na2SO4, filtered and concentrated under reduced pressure.
 
(S)-2-((R)-3,4-bis(benzyloxy)-5-oxo-2,5-dihydrofuran-2-yl)-2-hydroxyethyl 3-(phenyl-thio)propanoate (11a). 
Following the general procedure GP4, 5b (205 mg, 0.50 mmol, 1 eq.), neutral alumina (100 mg) and 
benzenethiol (66 mg, 0.60 mmol, 1 eq.) in dry toluene (5.0 mL), gave after flash chromatography (petroleum 
ether/EtOAc 3:1), 11a (239 mg, 92%). Yellowish oil. 
1
H NMR (400 MHz, CDCl3): δ (ppm) 2.23 (bs, 1H), 2.65 (ap t, 
J 7.4 Hz, 2H), 3.16 (ap t, J 7.4 Hz, 2H), 4.02-4.11 (m, 1H, CHCH2), 4.22 (dd, J 5.1, 11.4 Hz, 1H, CHaHbO), 4.34 (dd, 
J 6.6, 11.4 Hz, 1H, CHaHbO), 4.67 (d, J 2.2 Hz, 1H, CHO), 5.10 (ap. s, 2H, CH2Ph), 5.12 (d, J 11.2, 1H, CH2Ph), 5.21 
(d, J 11.2 Hz, 1H, CH2Ph), 7.20-7.38 (m, 15H). 
13
C NMR (100 MHz, CDCl3): δ (ppm) 28.9, 34.1, 64.9, 67.6, 73.6, 
73.8, 75.4, 121.1, 126.6, 127.8, 128.5, 128.6, 128.7, 129.0, 130.1, 134.8, 135.1, 135.8, 156.7, 169.4, 171.2. 
Elemental Analysis: C29H28O7S C 66.91%, H 5.42%. Found: C 66.69%, H 5.43%. 
(S)-2-((R)-3,4-bis((4-methoxybenzyl)oxy)-5-oxo-2,5-dihydrofuran-2-yl)-2-hydroxyethyl 3-(phenylthio)-
propanoate (11b). Following the general procedure GP4, 5c (118 mg, 0.25 mmol, 1 eq.), neutral alumina (50 
mg) and benzenethiol (33 mg, 0.30 mmol, 1 eq.) in dry toluene (2.5 mL), gave after flash chromatography 
(petroleum ether/EtOAc 3:1), 11b (131 mg, 91%) as a yellowish oil. 
1
H NMR (400 MHz, CDCl3): δ (ppm) 2.10 
(bs, 1H), 2.64 (ap t, J 7.3 Hz, 2H), 3.14 (ap t, J 7.3 Hz, 2H), 3.79 (s, 3H), 3.80 (s, 3H), 3.97-4.14 (m, 1H, CHCH2), 
4.19 (dd, J 5.1, 11.4 Hz, 1H, CHaHbO), 4.31 (dd, J 6.7, 11.4 Hz, 1H, CHaHbO), 4.62 (d, J 2.2 Hz, 1H, CHO), 5.02 (d, J 
11.2 Hz, 1H), 5.06 (ap. s, 2H), 5.12 (d, J 11.2 Hz, 1H), 6.83-6.92 (m, 4H), 7.12-7.38 (m, 9H). Elemental Analysis: 
C31H32O9S C 64.13%, H 5.56%. Found C 64.26%, H 5.21%. 
(S)-1-((R)-3,4-bis(benzyloxy)-5-oxo-2,5-dihydrofuran-2-yl)ethane-1,2-diyl bis(3-(phenyl-thio)propanoate) 
(12). Following the general procedure GP4, 3g (116 mg, 0.25 mmol, 1 eq.), neutral alumina (50 mg) and 
benzenethiol (66 mg, 0.60 mmol, 2.4 eq.) in dry toluene (2.5 mL), gave after flash chromatography (petroleum 
ether/EtOAc 5:1), 12 (152 mg, 88%) as a yellowish oil. 
1
H NMR (400 MHz, CDCl3): δ (ppm) 2.44-2.57 (m, 2H), 
2.62 (ap t, J 7.3 Hz, 2H), 3.06 (ap t, J 7.4 Hz, 2H), 3.14 (ap t, J 7.4 Hz, 2H), 4.27 (dd, J 7.2, 11.6 Hz, 1H, CHaHbO), 
4.36 (dd, J 5.3, 11.6 Hz, 1H, CHaHbO), 4.80 (d, J 2.2 Hz, 1H, CHO), 5.12 (AB system, ls 10.8 Hz, 2H, CH2Ph), 5.20 
(AB system, ls 11.3 Hz, 2H, CH2Ph) 5.41 (ddd, J 2.2, 5.3, 7.2 Hz, 1H, CHCH2), 7.17-7.37 (m, 20H). 
13
C NMR (100 
MHz, CDCl3): δ (ppm) 28.8, 29.1, 33.8, 34.1, 62.2, 67.7, 73.6, 73.5, 73.6, 73.7, 121.3, 126.6, 126.7, 127.4, 128.1, 
128.6, 128.7, 128.8, 128.9, 129.0, 129.1, 130.1, 130.3, 134.9, 135.0, 135.8, 154.8, 168.4, 170.2, 170.9. MS (ESI 
positive) m/z (%): 708 [M+Na]
+
, (100). Elemental Analysis: C38H36O8S2 C 66.65%, H 5.30%. Found: C 66.78%, H 
5.27%. 
Bis((S)-2-((R)-3,4-bis(benzyloxy)-5-oxo-2,5-dihydrofuran-2-yl)-2-hydroxyethyl) 3,3'-(ethane-1,2-diylbis-
(sulfanediyl))dipropionate (13). Following the general procedure GP4, 5b (103 mg, 0.25 mmol, 1 eq.), neutral 
alumina (25 mg) and 1,2-ethanedithiol (10.6 mg, 0.11 mmol, 0.45 eq.) in dry toluene (2 mL), gave after flash 
chromatography (petroleum ether/EtOAc 3:2), 13 ( 95 mg, 94%). Slightly yellow oil. 
1
H NMR (200 MHz, CDCl3): 
δ (ppm) 2.61-2.93 (m, 12H), 3.38 (bd, J 7.9 Hz, 2H, OH), 4.05-4.20 (m, 2H), 4.27 (dd, J 5.6, 11.3 Hz, 2H, CHaHbO), 
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4.36 (dd, J 7.0, 11.3 Hz, 2H, CHaHbO), 4.74 (d, J 1.9 Hz, 2H, CHO), 5.06 (ap s, 4H, CH2Ph), 5.07 (d, J 11.6 Hz, 2H, 
CH2Ph), 5.22 (d, J 11.6 Hz, 4H, CH2Ph), 7.17-7.26 (m, 4H), 7.32-7.43 (m, 16H). 
13
C NMR (50 MHz, CDCl3): δ 
(ppm) 26.6, 31.9, 35.0, 65.1, 67.7, 73.7, 74.0, 75.7, 121.3, 127.9, 128.6, 128.7, 129.1, 135.3, 135.9, 156.9, 
169.9, 171.8. Elemental Analysis: C48H50O14S2 C 63.01%, H 5.51%. Found C 62.86%, H 5.39%. 
 
 
References 
 
1. Tanini, D.; Degl’Innocenti, A.; Capperucci, A.  Eur. J. Org. Chem. 2015, 357 and references cited therein. 
http://dx.doi.org/10.1002/ejoc.201403015 
2. Capperucci, A.; Tanini, D.; Borgogni, C.; Degl’Innocenti, A. Heteroat. Chem. 2014, 25, 678. 
http://dx.doi.org/10.1002/hc.21157 
3. Tanini, D.; Barchielli, G.; Benelli, F.; Degl’Innocenti, A.; Capperucci, A. Phosphorus, Sulfur, Silicon Relat. 
Elem. 2015, 190, 1265.         
http://dx.doi.org/10.1080/10426507.2014.1002615 
4. García Ruano, J. L.; Torrente, E.; Alonso, I.; Rodriguez, M.; Martín-Castro, A. M.;  Degl’Innocenti, A.; 
Frateschi, L.; Capperucci, A. J. Org. Chem. 2012, 77, 1974.     
http://dx.doi.org/10.1021/jo202611v 
5. Capperucci, A.; Degl’Innocenti, A.; Tiberi, C. Synlett  2011, 2248.  
http://dx.doi.org/10.1055/s-0030-1261195 
6.  Menichetti, S.; Capperucci, A.; Tanini, D.; Braga, A. L.; Botteselle, G. V.; Viglianisi, C. Eur. J. Org. Chem. 
2016, 3097.              
http://dx.doi.org/10.1002/ejoc.201600351 
7. Vazquez-Prieto, M. A.; Miatello, R. M. Mol. Aspects Med. 2010, 31, 540 and references cited therein. 
http://dx.doi.org/10.1016/j.mam.2010.09.009 
8. Wirth, T. Organoselenium Chemistry. Synthesis and Reactions; Wiley-VCH Verlag & Co, Weinheim, 
Germany, 2012 and references cited therein.     
9. Tanini, D.; Panzella, L.; Amorati, R.; Capperucci, A.; Napolitano, A.; Menichetti, S.; d’Ischia, M. Org. 
Biomol. Chem. 2015, 5757.       
http://dx.doi.org/10.1039/C5OB00193E 
10.  Carretti, E.; Mazzini, V.; Fratini, E.; Ambrosi, M.; Dei, L.; Baglioni, P.; Lo Nostro, P. Phys. Chem. Chem. 
Phys. 2016, 18, 8865 and references cited therein.     
http://dx.doi.org/10.1039/C5CP07792C 
11. Venturini, C.; Pomposi, C.; Carretti, E.; Fratini, E.; Lo Nostro, P.; Baglioni, P. J. Phys. Chem. B 2014, 118, 
3053.            
http://dx.doi.org/10.1021/jp412127y 
12. Dolle, C.; Marangone, P.; Riva, S.; Ambrosi, M., Fratini, E.; Peruzzi, N.; Lo Nostro, P. J. Phys. Chem. B 2011, 
115, 11638.           
http://dx.doi.org/10.1021/jp204920y 
13. Lo Nostro, P.; Capuzzi, G.; Romani, A.; Mulinacci, N. Langmuir 2000, 16, 1744. 
http://dx.doi.org/10.1021/la990796j 
14. Palma, S.; Lo Nostro, P.; Manzo, R.; Allemandi, D. Eur. J. Pharm. Sci. 2002, 16, 37. 
http://dx.doi.org/10.1016/S0928-0987(02)00054-4 
Arkivoc 2017, (ii), 407-420  Tanini, D et al 
 
 Page 419  
©
ARKAT USA, Inc 
15. Lo Nostro, P.; Ninham, B.W.; Fratoni, L.; Palma, S.; Manzo, R.H.; Allemandi, D.; Baglioni, P. Langmuir 
2003, 19, 3222.            
http://dx.doi.org/10.1021/la026807h 
16.  Ambrosi, M.; Lo Nostro, P.; Fratoni, L.; Dei, L.; Ninham, B.W.; Palma, S.; Manzo, R.H.; Allemandi, D.; 
Baglioni, P. Phys. Chem. Chem. Phys. 2004, 6, 1401.      
http://dx.doi.org/10.1039/B314061J 
17. Ambrosi, M.; Lo Nostro, P.; Fratini, E.; Giustini, L.; Ninham, B. W.; Baglioni, P. J. Phys. Chem. B 2009, 113, 
1404–1412.           
http://dx.doi.org/10.1021/jp8092644 
18. Mottola, M.; Vico, R. V.; Villanueva, M. E.; Fanani, M. L. J. Colloid Interface Sci. 2015, 45, 232 and 
references cited therein.        
http://dx.doi.org/10.1016/j.jcis.2015.07.014 
19. Thopate, S.R.; Rohit A. Dengale, R.A.; Kulkarni, M.G. Synlett 2013, 1555.    
http://dx.doi.org/10.1055/s-0033-1338858 
20.  Karmee, S. K. Lipid Technol. 2011, 23, 227.      
http://dx.doi.org/10.1002/lite.201100146 
21. Tripathi, R. P.; Singh, B.; Singh Bisht, S.; Pandey, J. Curr. Org. Chem. 2009, 13, 99 and references cited 
therein.          
http://dx.doi.org/10.2174/138527209787193792 
22. Karmee, S. K. Appl. Microbiol. Biotechnol. 2009, 81, 1013.     
http://dx.doi.org/10.1007/s00253-008-1781-y 
23. Capuzzi, G.; Lo Nostro, P.; Kulkarni, K.; Fernandez, J. E. Langmuir 1996, 12, 3957 and references cited. 
24. Yoichi Ihori, Y.; Inoue, S.; Fujii, T.;  Osawa, Y.; Tanaka, T.; Ikeuchi, H. PCT Int. Appl. WO 2014050894, 2014; 
SciFinder Scholar 2014:528792. 
25. Choi, H.-I.; Kim, H.-J.; Park, J.-I.; Shin, E.-H.; Kim, D.-W.; Kim, S.-S. Bioorg. Med. Chem. Lett. 2009, 19, 
2079.  
http://dx.doi.org/10.1016/j.bmcl.2008.10.112 
26. Zhuang, D.; Nie, J.; Yang, J J. Polym. Sci., Part A: Polym. Chem. 2011, 49, 1999. 
http://dx.doi.org/10.1002/pola.24627 
27. Alam, M., Khan, M. H. J. Pharm. (Lahore) 1979, 1, 67.
 
28. Balen, M.; Silveira, C.; Kratz, J. M.; Simões, C.M.O.; Valério, A.; Ninow, J.L.; Nandi, L. G.; Di Luccio, M.; de 
Oliveira, D. Biocatal. Agric. Biotechnol. 2015, 4, 514 and references cited therein. 
29. Yan, R.; Jiang, C.; Li, Z.; Liu, L.; Jiang, X., Pat. Appl. CN 104480156 A, 2015; SciFinder Scholar  2015:567544. 
30. Stojanović, M.; Velićković, D.; Dimitrijević, A.; Milosavić, N.; Knežević-Jugović, Z.; Bezbradica, D. J. Oleo 
Sci. 2013, 62, 591.          
http://dx.doi.org/10.5650/jos.62.591 
31. Moreno-Perez, S.; Filice, M.; Guisan, J.M.; Fernandez-Lorente, G. Chem. Phys. Lipids 2013, 174, 48. 
http://dx.doi.org/10.1016/j.chemphyslip.2013.06.003 
32. Reyes-Duarte, D.; Lopez-Cortes, N.; Torres, P.; Comelles, F.; Parra, J. L.; Peña, S.; Ugidos, A. V.; 
Ballesteros, A.; Plou, F. J. J. Am. Oil Chem. Soc. 2011, 88, 57.      
http://dx.doi.org/10.1007/s11746-010-1643-5 
33. Kaiyal, M. U.S. Pat. Appl. US 20110151525 A1, 2011; SciFinder Scholar 2011:787884.  
Arkivoc 2017, (ii), 407-420  Tanini, D et al 
 
 Page 420  
©
ARKAT USA, Inc 
34. Adamczak, M.; Bornscheuer, U. T. Process Biochem. 2009, 44, 257. 
http://dx.doi.org/10.1016/j.procbio.2008.10.014 
35. Kim, J. D.;  Han, G.; Zee, O. P.; Jung, Y. H. Tetrahedron Lett. 2003, 44, 733. 
http://dx.doi.org/10.1016/S0040-4039(02)02648-5
 
36. Jung, M. E.; Koch, P. Tetrahedron Lett. 2011, 52, 6051.   
http://dx.doi.org/10.1016/j.tetlet.2011.08.102 
37. Yu, W.; Su, M.; Gao, X.; Yang, Z.; Jin, Z. Tetrahedron Lett. 2000, 41, 4015.   
http://dx.doi.org/10.1016/S0040-4039(00)00574-8 
38. Máté Kicsák, M.; Bege, M.; Bereczki, I.; Csávás, M.; Herczeg, M.; Kupihár, Z.; Kovács, L.; Borbás, A.; 
Herczegh, P. Org. Biomol. Chem. 2016, 14, 3190 and references cited therein. 
http://dx.doi.org/10.1039/C6OB00067C
 
39. Suzuki, Y.; Saitoh, G.; Nawa, S.; Kodomari, M. Nippon Kagaku Kaishi 1998, 12, 824. 
http://dx.doi.org/10.1246/nikkashi.1998.824 
40. Goupy, P.;  Dufour, C.; Loonis, M.; Dangles, O. J. Agric. Food Chem., 2003, 51, 615. 
http://dx.doi.org/10.1021/jf025938l 
41. Ravindar, K., Caron, P-I., Deslongchamps, P. J. Org. Chem., 2014, 79, 17, 7979.  
 
 
